2-(6-Fluoropyridin-3-yl)-5-methoxy-3H-imidazo[4,5-b]pyridine

Catalog No. :
ACVUOF541
CAS No. :
1356386-00-9
Molecular Formula :
C12H9FN4O
Molecular Weight :
244.23

IUPAC Name:2-(6-fluoropyridin-3-yl)-5-methoxy-1H-imidazo[4,5-b]pyridine

2-(6-Fluoropyridin-3-yl)-5-methoxy-3H-imidazo[4,5-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$343.00Login to see priceInquiryInquiry
1g97%$859.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(6-Fluoropyridin-3-yl)-5-methoxy-3H-imidazo[4,5-b]pyridine
IUPAC Name2-(6-fluoropyridin-3-yl)-5-methoxy-1H-imidazo[4,5-b]pyridine
MDL No.MFCD22690108
Molecular FormulaC12H9FN4O
Molecular Weight244.23
SMILESCOC1=CC=C2C(NC(C3=CC=C(F)N=C3)=N2)=N1
InChI KeyMTTAXCAEQTXOCX-UHFFFAOYSA-N
Synonym2-(6-FLUOROPYRIDIN-3-YL)-5-METHOXY-3H-IMIDAZO[4,5-B]PYRIDINE;3H-Imidazo[4,5-b]pyridine, 2-(6-fluoro-3-pyridinyl)-5-methoxy-
CAS No.1356386-00-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVUOF541 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACURYX390 route compound structure diagram
    ACURYX39094166-62-8 In Stock
  2. Plus
  3. ACWUGY947 route compound structure diagram
    ACWUGY947677728-92-6 In Stock
  4. Then
  5. ACVUOF541 route product structure diagram
    ACVUOF5411356386-00-9
Inquiry

2. ACVUOF541 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACURYX390 route compound structure diagram
    ACURYX39094166-62-8 In Stock
  2. Plus
  3. ACDGBN409 route compound structure diagram
    ACDGBN409403-45-2 In Stock
  4. Then
  5. ACVUOF541 route product structure diagram
    ACVUOF5411356386-00-9
Inquiry

Comments (0)